Worldwide, ∼1 million people manage their diabetes with an insulin pump, rapid acting insulin, and a continuous subcutaneous insulin infusion (CSII) catheter.1 Insulin is continuously delivered through the CSII catheter at a variable basal rate between meals and during sleep. This evidence concerns the gene INS and diabetes mellitus.